🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pulmonary Arterial Hypertension (PAH)

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) NCT06649110Phase 1, Phase 287 sites📍 Scottsdale📍 Orange📍 Stanford Novartis Pharmaceuticals · Tests: LTP, Placebo Hormonal, Metabolic, and Signaling Interactions in PAH NCT01884051n/a1 site📍 Nashville Vanderbilt University Medical Center PET Image in PAH Patients NCT05452889EARLY Phase 11 site📍 Pittsburgh Stephen Y. Chan · Tests: 18F-FGLN PET Imaging, (18F)FPGLU A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension NCT06554301Phase 11 site📍 Beijing China National Center for Cardiovascular Diseases · Tests: empagliflozin in treatment pulmonary aerterial hypertension, placebo in treatment pulmonary aerterial hypertension Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension NCT05566002n/a1 site📍 Beijing Chinese Pulmonary Vascular Disease Research Group · Tests: Right heart catheterization Comparison of Sequential to Initial Combination Therapy in PAH NCT06968962NA1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Tadalafil, Ambrisentan, Ambrisentan mimic, Tadalafil mimic Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Chronic Lung Diseases NCT07777367NA1 site📍 Zurich Silvia Ulrich Somaini · Tests: 6-minute walk distance (6MWD) test on ambient conditions, 6-minute walk distance (6MWD) test with supplemental oxygen (… Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial Hypertension NCT07713914Phase 41 site📍 São Paulo University of Sao Paulo General Hospital · Tests: Prostacyclin Pathway Agent, Sildenafil Dose Optimization A Study of Inhaled Treprostinil (LIQ861) in Adults With Pulmonary Arterial Hypertension Transitioning From Oral Selexipag NCT07759804Phase 41 site📍 Columbus Liquidia Technologies, Inc. · Tests: LIQ861 (treprostinil) inhalation powder 129 Xenon Imaging in Patients Treated With Sotatercept NCT06351345Phase 21 site📍 Durham Bastiaan Driehuys · Tests: 129Xe Hyperpolarized Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Pulmonary Vascular Disease (PVD) NCT07777445NA1 site📍 Zurich Silvia Ulrich Somaini · Tests: 6-minute walk distance (6MWD) test on ambient conditions, 6-minute walk distance (6MWD) test with supplemental oxygen (… Xenon MRI Pulm Hypertension NCT04991454Phase 21 site📍 Durham Bastiaan Driehuys · Tests: 129Xe Hyperpolarized DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL NCT03959748n/a1 site📍 Krakow Polish Cardiology Association Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals NCT05584722n/a1 site📍 Nashville Vanderbilt University Medical Center Potts-shunt for the Treatment of Pediatric Patients With Severe Pulmonary Hypertension NCT06429579NA1 site📍 Beijing China National Center for Cardiovascular Diseases · Tests: Comprehensive therapy combined Potts-shunt procedure and conventional drug therapy, Only conventional drug therapy Taiwan Interstitial Lung Disease Multi-center Investigation and Registry NCT06476470n/a1 site📍 Taichung Taichung Veterans General Hospital A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy. NCT07593027Phase 1, Phase 229 sites📍 Beijing📍 Jilin City📍 Jilin City ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. · Tests: IMC-003 and PAH background therapy, IMC-003 placebo and PAH background therapy PAH Exercise Study NCT06941441Phase 31 site📍 Seattle University of Washington · Tests: Home exercise program 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH) NCT06104228Phase 21 site📍 Durham Bastiaan Driehuys · Tests: 129Xe Hyperpolarized A Trial of "APL-9796'' in Adults With Pulmonary Hypertension NCT06846554Phase 26 sites📍 London📍 Bath📍 Cambridge Apollo Therapeutics Ltd · Tests: APL-9796, APL-9796 Multicenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligence for Patients With Systemic Sclerosis NCT07236970n/a5 sites📍 Granada📍 Santander📍 Barcelona Alejandro Cruz Utrilla Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass NCT07132788n/a2 sites📍 Philadelphia📍 Providence University of Pennsylvania · Tests: blood draw, Short Performance Physical Battery, Grip strength test, Six minute walk test, Chest CT scan The Effect of Additive On-Demand Sildenafil vs. Dextrose Candy on Maximum Exercise Capacity in Pulmonary Arterial Hypertension NCT07824674Phase 2, Phase 31 site📍 Zurich Silvia Ulrich · Tests: Dextrose, Sildenafil 20mg Registry of Patients With chrOnic thromboemboLic Pulmonary hypErTension NCT07254078n/a1 site📍 Moscow Irina E. Chazova · Tests: Pulmonary endarterectomy, Balloon pulmonary angioplasty, Pulmonary hypertension-specific therapy Continuous Effect Of Rehabilitation Training On Pulmonary Arterial Hypertension Patients NCT07149935NA1 site📍 Shanghai RenJi Hospital · Tests: Rehabilitation Training Digital Assessment of Real-World Walking Activity in Pulmonary Hypertension: A Prospective Multicenter Trial NCT07137260n/a4 sites📍 Stuttgart📍 Munich📍 Nuremberg Simon Jäger · Tests: Accelerometer (measurement of walking activity) Exercise Intervention as an Adjunct to Medical Therapy in Newly Diagnosed Patients With Pulmonary Arterial Hypertension NCT07366879NA1 site📍 Glasgow Golden Jubilee National Hospital · Tests: Home-based, remotely delivered, supervised Exercise programme imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce NCT06850792NA1 site📍 São Paulo University of Sao Paulo General Hospital · Tests: Telemedicine-Based Adherence Support Home-Based Clinical Management of Cardiac Complications in Systemic Sclerosis NCT06865118n/a1 site📍 Oslo Oslo University Hospital A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032) NCT07646860Phase 23 sites📍 Izumi📍 Suita📍 Setagaya City Merck Sharp & Dohme LLC · Tests: Sotatercept
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy